FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”
In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment
NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups
Review Group Report: NCI Role In Drug Development Seen As Information Provider
NCI Offers Model Informed Consent Documents
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored









